PSA-话题@MedSci

#PSA#

59篇内容 | 3160人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1271061, encodeId=1fd312e1061e0, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=Ann Rheum Dis：银屑病关节炎疾病影响（PsAID）问卷的验证及其在临床实践中作为单项结局指标的潜力, objectType=article, longId=120550, objectId=b0831205503f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0831205503f, replyNumber=0, likeNumber=67, createdTime=2017-11-19, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0831205503f, moduleTitle=Ann Rheum Dis：银屑病关节炎疾病影响（PsAID）问卷的验证及其在临床实践中作为单项结局指标的潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0831205503f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271060, encodeId=2e2312e106005, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=JCLA：健康汉族男性tPSA、fPSA和% fPSA的年龄特异性参考区间如何？, objectType=article, longId=106481, objectId=a44e10648191, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a44e10648191, replyNumber=0, likeNumber=69, createdTime=2017-07-26, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a44e10648191, moduleTitle=JCLA：健康汉族男性tPSA、fPSA和% fPSA的年龄特异性参考区间如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a44e10648191)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271059, encodeId=33b312e105916, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=查前列腺癌：指检和血清PSA缺一不可, objectType=article, longId=102203, objectId=6d11102203b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d11102203b0, replyNumber=0, likeNumber=85, createdTime=2017-06-18, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d11102203b0, moduleTitle=查前列腺癌：指检和血清PSA缺一不可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d11102203b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271058, encodeId=445e12e1058d0, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=喜讯！诺华重磅抗炎药Cosentyx获英国NICE批准治疗银屑病关节炎（PsA）, objectType=article, longId=86942, objectId=2a528694223, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a528694223, replyNumber=0, likeNumber=60, createdTime=2017-01-09, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a528694223, moduleTitle=喜讯！诺华重磅抗炎药Cosentyx获英国NICE批准治疗银屑病关节炎（PsA）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a528694223)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271057, encodeId=2d7e12e10570d, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=抗TNF治疗会增加AS、PsA、SpA患者的结核病风险, objectType=article, longId=82440, objectId=1950824406e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1950824406e, replyNumber=0, likeNumber=67, createdTime=2016-11-17, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1950824406e, moduleTitle=抗TNF治疗会增加AS、PsA、SpA患者的结核病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1950824406e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271056, encodeId=1a6712e10564e, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=他汀类药物治疗可降低AS+PsA患者的心血管风险和总死亡率, objectType=article, longId=82365, objectId=6f0c823659c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f0c823659c, replyNumber=0, likeNumber=67, createdTime=2016-11-16, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f0c823659c, moduleTitle=他汀类药物治疗可降低AS+PsA患者的心血管风险和总死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f0c823659c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271055, encodeId=798e12e1055fe, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=Clin Nutr：番茄能降低前列腺癌患者的前列腺特异性抗原(PSA)水平, objectType=article, longId=74676, objectId=ad6ae4676db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad6ae4676db, replyNumber=0, likeNumber=43, createdTime=2016-08-09, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad6ae4676db, moduleTitle=Clin Nutr：番茄能降低前列腺癌患者的前列腺特异性抗原(PSA)水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad6ae4676db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271054, encodeId=4f9612e1054e6, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=JCO：中年人的PSA水平能预测将来前列腺癌的死亡率, objectType=article, longId=71683, objectId=081de168379, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=081de168379, replyNumber=0, likeNumber=71, createdTime=2016-06-29, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=081de168379, moduleTitle=JCO：中年人的PSA水平能预测将来前列腺癌的死亡率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=081de168379)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271053, encodeId=6d5612e105371, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=血清肿瘤标志物PSA检测助力前列腺癌有效管理, objectType=article, longId=66675, objectId=039c666e56b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=039c666e56b, replyNumber=0, likeNumber=42, createdTime=2016-04-20, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=039c666e56b, moduleTitle=血清肿瘤标志物PSA检测助力前列腺癌有效管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=039c666e56b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271052, encodeId=aeb412e105267, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=血清肿瘤标志物PSA检测助力前列腺癌有效管理, objectType=article, longId=63693, objectId=67e7636932b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67e7636932b, replyNumber=0, likeNumber=85, createdTime=2016-02-25, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67e7636932b, moduleTitle=血清肿瘤标志物PSA检测助力前列腺癌有效管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67e7636932b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271051, encodeId=c71612e105147, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=PSA的筛查率下降，是否就会有更多的男性死于前列腺癌？, objectType=article, longId=59068, objectId=6d2d59068af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d2d59068af, replyNumber=0, likeNumber=61, createdTime=2015-11-20, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d2d59068af, moduleTitle=PSA的筛查率下降，是否就会有更多的男性死于前列腺癌？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d2d59068af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271050, encodeId=39aa12e10506d, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=1美元前列腺癌筛查技术或明显优于PSA检测技术, objectType=article, longId=49371, objectId=a7f8493e1e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7f8493e1e3, replyNumber=0, likeNumber=68, createdTime=2015-04-16, rootId=0, userName=zhaozhouchifen, userId=524d95, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7f8493e1e3, moduleTitle=1美元前列腺癌筛查技术或明显优于PSA检测技术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7f8493e1e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271049, encodeId=b8ed12e1049ba, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=前列腺癌：PSA筛查程序开发优化, objectType=article, longId=47021, objectId=245e4e021a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=245e4e021a5, replyNumber=0, likeNumber=94, createdTime=2015-02-13, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=245e4e021a5, moduleTitle=前列腺癌：PSA筛查程序开发优化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=245e4e021a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271048, encodeId=1ea812e10485b, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=JCO：前列腺癌筛查，新型前列腺特异抗原（PCA3）能否成为PSA的补充？, objectType=article, longId=44837, objectId=dd594483ed7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd594483ed7, replyNumber=0, likeNumber=80, createdTime=2014-12-31, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd594483ed7, moduleTitle=JCO：前列腺癌筛查，新型前列腺特异抗原（PCA3）能否成为PSA的补充？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd594483ed7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271047, encodeId=d27812e104734, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=ASCO 2014：复发PSA患者即刻ADT 无必要, objectType=article, longId=35332, objectId=e93d3533225, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e93d3533225, replyNumber=0, likeNumber=81, createdTime=2014-05-28, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e93d3533225, moduleTitle=ASCO 2014：复发PSA患者即刻ADT 无必要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e93d3533225)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271046, encodeId=2a3d12e104658, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=ASCO 2014：复发PSA患者即刻ADT 无必要, objectType=article, longId=34987, objectId=4e5c3498ea8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e5c3498ea8, replyNumber=0, likeNumber=92, createdTime=2014-05-22, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e5c3498ea8, moduleTitle=ASCO 2014：复发PSA患者即刻ADT 无必要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e5c3498ea8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271045, encodeId=492412e104565, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=ACR：PsA的心血管病疾病发病风险高于RA, objectType=article, longId=34471, objectId=9e51344e155, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e51344e155, replyNumber=0, likeNumber=73, createdTime=2014-05-10, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e51344e155, moduleTitle=ACR：PsA的心血管病疾病发病风险高于RA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e51344e155)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271044, encodeId=375b12e104481, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=JAMA：前列腺癌PSA筛查或可提高阈值, objectType=article, longId=32359, objectId=9b403235988, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b403235988, replyNumber=0, likeNumber=74, createdTime=2014-03-27, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b403235988, moduleTitle=JAMA：前列腺癌PSA筛查或可提高阈值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b403235988)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271043, encodeId=0fe912e104333, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=JNCI：PSA筛查并不能预测前列腺癌特异性死亡事件的发生, objectType=article, longId=17367, objectId=5d481e36712, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d481e36712, replyNumber=0, likeNumber=61, createdTime=2013-04-14, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d481e36712, moduleTitle=JNCI：PSA筛查并不能预测前列腺癌特异性死亡事件的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d481e36712)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271042, encodeId=e08e12e1042ed, content=<a href='/topic/show?id=4cfa14e8911' target=_blank style='color:#2F92EE;'>#PSA#</a>, objectTitle=ACP新指南认为PSA筛查弊大于利, objectType=article, longId=17040, objectId=81721e04061, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81721e04061, replyNumber=0, likeNumber=69, createdTime=2013-04-12, rootId=0, userName=智慧医人, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81721e04061, moduleTitle=ACP新指南认为PSA筛查弊大于利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81721e04061)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PSA

2020-05-29

zhaozhouchifen (审核中...)

前往app查看评论内容

#PSA#

Ann Rheum Dis：银屑病关节炎疾病影响（PsAID）问卷的验证及其在临床实践中作为单项结局指标的潜力

2017-11-19

zhaozhouchifen (审核中...)

前往app查看评论内容

#PSA#

JCLA：健康汉族男性tPSA、fPSA和% fPSA的年龄特异性参考区间如何？

2017-07-26

zhaozhouchifen (审核中...)

前往app查看评论内容

#PSA#

查前列腺癌：指检和血清PSA缺一不可

2017-06-18

zhaozhouchifen (审核中...)

前往app查看评论内容

#PSA#

喜讯！诺华重磅抗炎药Cosentyx获英国NICE批准治疗银屑病关节炎（PsA）

2017-01-09

zhaozhouchifen (审核中...)

前往app查看评论内容

#PSA#

抗TNF治疗会增加AS、PsA、SpA患者的结核病风险

2016-11-17

zhaozhouchifen (审核中...)

前往app查看评论内容

#PSA#

他汀类药物治疗可降低AS+PsA患者的心血管风险和总死亡率

2016-11-16

zhaozhouchifen (审核中...)

前往app查看评论内容

#PSA#

Clin Nutr：番茄能降低前列腺癌患者的前列腺特异性抗原(PSA)水平

2016-08-09

zhaozhouchifen (审核中...)

前往app查看评论内容

#PSA#

JCO：中年人的PSA水平能预测将来前列腺癌的死亡率

2016-06-29

zhaozhouchifen (审核中...)

前往app查看评论内容

#PSA#

血清肿瘤标志物PSA检测助力前列腺癌有效管理

2016-04-20

zhaozhouchifen (审核中...)

前往app查看评论内容

#PSA#

血清肿瘤标志物PSA检测助力前列腺癌有效管理

2016-02-25

zhaozhouchifen (审核中...)

前往app查看评论内容

#PSA#

PSA的筛查率下降，是否就会有更多的男性死于前列腺癌？

2015-11-20

zhaozhouchifen (审核中...)

前往app查看评论内容

#PSA#

1美元前列腺癌筛查技术或明显优于PSA检测技术

2015-04-16

智慧医人 (审核中...)

前往app查看评论内容

#PSA#

前列腺癌：PSA筛查程序开发优化

2015-02-13

智慧医人 (审核中...)

前往app查看评论内容

#PSA#

JCO：前列腺癌筛查，新型前列腺特异抗原（PCA3）能否成为PSA的补充？

2014-12-31

智慧医人 (审核中...)

前往app查看评论内容

#PSA#

ASCO 2014：复发PSA患者即刻ADT 无必要

2014-05-28

智慧医人 (审核中...)

前往app查看评论内容

#PSA#

ASCO 2014：复发PSA患者即刻ADT 无必要

2014-05-22

智慧医人 (审核中...)

前往app查看评论内容

#PSA#

ACR：PsA的心血管病疾病发病风险高于RA

2014-05-10

智慧医人 (审核中...)

前往app查看评论内容

#PSA#

JAMA：前列腺癌PSA筛查或可提高阈值

2014-03-27

智慧医人 (审核中...)

前往app查看评论内容

#PSA#

JNCI：PSA筛查并不能预测前列腺癌特异性死亡事件的发生

2013-04-14

智慧医人 (审核中...)

前往app查看评论内容

#PSA#

ACP新指南认为PSA筛查弊大于利

2013-04-12

科室
- - 订阅+
  - 更多科室
工具
服务